A randomised dose comparison study of recombinant human growth hormone effects on metabolism markers in children with growth hormone (GH) deficiency
Completed
- Conditions
- utritional, Metabolic, Endocrine: Growth hormone deficiencyNutritional, Metabolic, EndocrineGrowth hormone deficiency
- Registration Number
- ISRCTN44127724
- Lead Sponsor
- Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Recruitment and number of subjects: Maximum recruitment of five pre-pubertal newly diagnosed GH-deficient patients in whom a clinical decision is made that they would benefit from treatment with GH and who wish to take part in study (subject to inclusion/exclusion criteria in accordance with protocol).
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method